Tao L - Search Results

1

Pyroptosis-related signatures predict immune characteristics and prognosis in IPF.

He Y, Yao T, Zhang Y, Long L, Jiang G, Zhang X, Lv X, Han Y, Cheng X, Li M, Jiang M, Peng Z, Tao L, Meng J. He Y, et al. Among authors: tao l. Heliyon. 2023 Dec 13;10(1):e23683. doi: 10.1016/j.heliyon.2023.e23683. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38192798 Free PMC article.

2

[Dynamic observation of enalapril on the expression of TGF-beta1, CTGF, Smad7 and alpha-SMA in rats with unilateral ureteral obstruction].

Wang L, Ning W, Tao L, Wang L, Peng Z. Wang L, et al. Among authors: tao l. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Mar;34(3):252-8. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009. PMID: 19349682 Chinese.

3

[Losartan inhibits high glucose-induced CTGF expression via ERK1/2 MAPK pathways in mouse mesangial cells].

Wang L, Tao LJ, Peng ZZ, Ning WB. Wang L, et al. Among authors: tao lj. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Jun;25(6):486-9. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009. PMID: 19500499 Chinese.

4

Fluorofenidone attenuates collagen I and transforming growth factor-beta1 expression through a nicotinamide adenine dinucleotide phosphate oxidase-dependent way in NRK-52E cells.

Peng ZZ, Hu GY, Shen H, Wang L, Ning WB, Xie YY, Wang NS, Li BX, Tang YT, Tao LJ. Peng ZZ, et al. Among authors: tao lj. Nephrology (Carlton). 2009 Sep;14(6):565-72. doi: 10.1111/j.1440-1797.2009.01129.x. Nephrology (Carlton). 2009. PMID: 19712256

5

Fluorofenidone inhibits TGF-beta1 induced CTGF via MAPK pathways in mouse mesangial cells.

Wang L, Hu GY, Shen H, Peng ZZ, Ning WB, Tao LJ. Wang L, et al. Among authors: tao lj. Pharmazie. 2009 Oct;64(10):680-4. Pharmazie. 2009. PMID: 19947172

6

Fluorofenidone protects mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-1beta release.

Tang Y, Li B, Wang N, Xie Y, Wang L, Yuan Q, Zhang F, Qin J, Peng Z, Ning W, Wang L, Hu G, Li J, Tao L. Tang Y, et al. Among authors: tao l. Int Immunopharmacol. 2010 May;10(5):580-3. doi: 10.1016/j.intimp.2010.02.005. Epub 2010 Feb 13. Int Immunopharmacol. 2010. PMID: 20159052

7

Fluorofenidone inhibits Ang II-induced apoptosis of renal tubular cells through blockage of the Fas/FasL pathway.

Ning WB, Hu GY, Peng ZZ, Wang L, Wang W, Chen JY, Zheng X, Li J, Tao LJ. Ning WB, et al. Among authors: tao lj. Int Immunopharmacol. 2011 Sep;11(9):1327-32. doi: 10.1016/j.intimp.2011.04.016. Epub 2011 May 14. Int Immunopharmacol. 2011. PMID: 21586345

8

Fluorofenidone attenuates renal interstitial fibrosis in the rat model of obstructive nephropathy.

Li BX, Tang YT, Wang W, Xie YY, Wang NS, Yuan QJ, Zhang FF, Peng ZZ, Hu GY, Tao LJ. Li BX, et al. Mol Cell Biochem. 2011 Aug;354(1-2):263-73. doi: 10.1007/s11010-011-0826-1. Epub 2011 May 19. Mol Cell Biochem. 2011. PMID: 21594754

9

Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.

Yuan Q, Wang R, Peng Y, Fu X, Wang W, Wang L, Zhang F, Peng Z, Ning W, Hu G, Wang Z, Tao L. Yuan Q, et al. Among authors: tao l. Am J Nephrol. 2011;34(2):181-94. doi: 10.1159/000329080. Epub 2011 Jul 23. Am J Nephrol. 2011. PMID: 21791914

10

Fluorofenidone suppresses epithelial-mesenchymal transition and the expression of connective tissue growth factor via inhibiting TGF-beta/Smads signaling in human proximal tubular epithelial cells.

Yuan Q, Wang L, Zhang F, Wang R, Fu X, Peng Z, Ning W, Hu G, Wang Z, Tao L. Yuan Q, et al. Among authors: tao l. Pharmazie. 2011 Dec;66(12):961-7. Pharmazie. 2011. PMID: 22312703

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,396 results

Search Page

Filters